{"table-1017-538": {"title": ["Hormone", "Other names", "Symbol(s)", "Structure", "Secretory cells", "Staining", "Target", "Effect"], "numCols": 8, "numericColumns": [], "pgTitle": "Anterior pituitary", "numDataRows": 7, "secondTitle": "Major hormones secreted", "numHeaderRows": 1, "caption": "Major hormones secreted", "data": [["[Adrenocorticotropic_hormone|Adrenocorticotropic hormone]", "Corticotropin", "ACTH", "Polypeptide", "[Corticotropic_cell|Corticotropic_cell]", "[Basophil_cell|Basophil]", "[Adrenal_gland|Adrenal gland]", "[Glucocorticoid|glucocorticoid]"], ["[Beta-Endorphin|Beta-Endorphin]", "", "", "Polypeptide", "[Corticotropic_cell|Corticotropic_cell]", "[Basophil_cell|Basophil]", "[Opioid_receptor|Opioid receptor]", "Inhibit perception of pain"], ["[Thyroid-stimulating_hormone|Thyroid-stimulating hormone]", "Thyrotropin", "TSH", "[Glycoprotein|Glycoprotein]", "[Thyrotropic_cell|Thyrotropic_cell]", "[Basophil_cell|Basophil]", "[Thyroid|Thyroid gland]", "[Thyroid_hormone|thyroid hormone]"], ["[Follicle-stimulating_hormone|Follicle-stimulating hormone]", "-", "FSH", "Glycoprotein", "[Gonadotropic_cell|Gonadotropic_cell]", "[Basophil_cell|Basophil]", "[Gonad|Gonad]", "[Reproductive_system|reproductive system]"], ["[Luteinizing_hormone|Luteinizing hormone]", "Lutropin", "LH, ICSH", "Glycoprotein", "[Gonadotropic_cell|Gonadotropic_cell]", "[Basophil_cell|Basophil]", "[Gonad|Gonad]", "[Sex_steroid|Sex hormone]"], ["[Growth_hormone|Growth hormone]", "Somatotropin", "GH, STH", "Polypeptide", "[Somatotropic_cell|Somatotropic_cell]", "[Acidophil_cell|Acidophil_cell]", "[Liver|Liver]", "[Lipid|lipid]"], ["[Prolactin|Prolactin]", "Lactogenic hormone", "PRL", "Polypeptide", "[Prolactin_cell|Prolactin_cell]", "[Acidophil_cell|Acidophil_cell]", "[Ovary|Ovaries]", "[Estrogen|estrogen]"]]}, "table-0520-707": {"title": ["Chemical class", "Name", "Abbreviation", "Tissue", "Cells", "Receptor", "Target Tissue", "Effect"], "numCols": 8, "numericColumns": [], "pgTitle": "List of human hormones", "numDataRows": 12, "secondTitle": "Steroid", "numHeaderRows": 1, "caption": "Steroid", "data": [["[Androgen|androgen]", "[Testosterone|Testosterone]", "", "[Testicle|testes]", "[Leydig_cell|Leydig cell]", "[Androgen_receptor|AR]", "", "[Libido|libido]"], ["[Androgen|androgen]", "[Dehydroepiandrosterone|Dehydroepiandrosterone]", "DHEA", "[Testicle|testes]", "[Zona_fasciculata|Zona fasciculata]", "[Androgen_receptor|AR]", "", "[Virilization|Virilization]"], ["[Androgen|androgen]", "[Androstenedione|Androstenedione]", "", "[Adrenal_gland|adrenal glands]", "", "[Androgen_receptor|AR]", "", "[Estrogen|estrogen]"], ["[Androgen|androgen]", "[Dihydrotestosterone|Dihydrotestosterone]", "DHT", "multiple", "", "[Androgen_receptor|AR]", "", "5-DHT or DHT is a male reproductive hormone that targets the prostate gland, bulbourethral gland, seminal vesicles, penis and scrotum and promotes growth/mitosis/cell maturation and differentiation. Testosterone is converted to 5-DHT by 5alpha-reductase, usually with in the target tissues of 5-DHT because of the need for high concentrations of 5-dht to produced the physiological effects."], ["[Mineralocorticoid|mineralocorticoid]", "[Aldosterone|Aldosterone]", "", "[Adrenal_cortex|adrenal cortex]", "", "[Mineralocorticoid_receptor|MR]", "", "[Blood_volume|blood volume]"], ["[Estrogen|estrogen]", "[Estradiol|Estradiol]", "E 2", "[Ovary|ovary]", "[Granulosa_cell|granulosa cells]", "[Estrogen_receptor|ER]", "", "[Secondary_sex_characteristic|secondary sex characteristics]"], ["[Estrogen|estrogen]", "[Estrone|Estrone]", "", "[Ovary|ovary]", "[Granulosa_cell|granulosa cells]", "[Estrogen_receptor|ER]", "", ""], ["[Estrogen|estrogen]", "[Estriol|Estriol]", "E 3", "[Placenta|placenta]", "[Syncytiotrophoblast|syncytiotrophoblast]", "[Estrogen_receptor|ER]", "", ""], ["[Glucocorticoid|glucocorticoid]", "[Cortisol|Cortisol]", "", "[Adrenal_cortex|adrenal cortex]", "", "[Glucocorticoid_receptor|GR]", "", "[Gluconeogenesis|gluconeogenesis]"], ["[Progestogen|progestogen]", "[Progesterone|Progesterone]", "", "[Ovary|ovary]", "[Granulosa_cell|Granulosa cells]", "[Progesterone_receptor|PR]", "", "[Pregnancy|pregnancy]"], ["[Secosteroid|secosteroid]", "[Calcitriol|Calcitriol]", "", "[Skin|skin]", "", "[Calcitriol_receptor|VDR]", "", "[Cholecalciferol|vitamin D 3 ]"], ["[Secosteroid|secosteroid]", "[Calcifediol|Calcifediol]", "", "[Skin|skin]", "", "[Calcitriol_receptor|VDR]", "", "[Cholecalciferol|vitamin D 3 ]"]]}, "table-1451-328": {"title": ["Secreted hormone", "Abbreviation", "Produced by", "Effect"], "numCols": 4, "numericColumns": [], "pgTitle": "Hypothalamus", "numDataRows": 6, "secondTitle": "Endocrine hormones", "numHeaderRows": 1, "caption": "Endocrine hormones", "data": [["[Thyrotropin-releasing_hormone|Thyrotropin-releasing hormone]", "TRH, TRF, or PRH", "[Parvocellular_neurosecretory_cell|Parvocellular neurosecretory cell]", "[Thyroid-stimulating_hormone|thyroid-stimulating hormone (TSH)]"], ["[Corticotropin-releasing_hormone|Corticotropin-releasing hormone]", "CRH or CRF", "Parvocellular neurosecretory cells of the paraventricular nucleus", "[Adrenocorticotropic_hormone|adrenocorticotropic hormone (ACTH)]"], ["[Dopamine|Dopamine]", "DA or PIH", "[Arcuate_nucleus|Dopamine neurons of the arcuate nucleus]", "[Prolactin|prolactin]"], ["[Growth-hormone-releasing_hormone|Growth hormone-releasing hormone]", "GHRH", "[Neuroendocrine_cell|Neuroendocrine_cell]", "[Growth_hormone|Growth hormone (GH)]"], ["[Gonadotropin-releasing_hormone|Gonadotropin-releasing hormone]", "GnRH or LHRH", "[Neuroendocrine_cell|Neuroendocrine_cell]", "[Follicle-stimulating_hormone|follicle-stimulating hormone (FSH)]"], ["[Somatostatin|Somatostatin]", "SS, GHIH, or SRIF", "[Neuroendocrine_cell|Neuroendocrine_cell]", "[Growth_hormone|Growth hormone (GH)]"]]}, "table-0116-212": {"title": ["Claim", "Evidence"], "numCols": 2, "numericColumns": [], "pgTitle": "Bioidentical hormone replacement therapy", "numDataRows": 10, "secondTitle": "Lack of evidence for claims", "numHeaderRows": 1, "caption": "Lack of evidence for claims", "data": [["Bioidentical hormones fit precisely into human hormone receptors while conventional hormones fit \"cockeyed\"; this mismatch causes serious side effects", "[Progestin|progestin]"], ["The body is unable to metabolize synthetic hormones", "[Biological_half-life|biological half-life]"], ["[Menstrual_cycle|menses]", "[Premenstrual_syndrome|premenstrual syndrome]"], ["[Stress_(biology)|stress]", "There is no evidence to support weight loss due to progesterone"], ["\"Normal\" levels of progesterone protect against breast cancer", "[Infertility|infertile]"], ["[Cardiovascular_disease|cardiovascular disease]", "The use of micronized progesterone does not affect cardiovascular risk"], ["The side effects reported in the Women's Health Initiative study were due to the synthetic nature of the hormones used", "\"Cardiovascular benefit has not been proven with micronized progesterone in observational or experimental research...a multicenter, case\u2013control study was conducted in postmenopausal women aged 45\u201370 years to examine potential differences in cardiovascular risk between the subtypes of synthetic progestins and micronized progesterone...Micronized progesterone and pregnane derivatives were not associated with an increased venous thromboembolism risk, whereas norpregnane derivatives...were associated with increased risk of thromboembolism...Thus, certain progestins are associated with increased cardiovascular risk, whereas pregnane derivatives and micronized progesterone neither increase nor decrease cardiovascular risk in the doses studied\""], ["Proponents claim that bioidentical hormones, in addition to the demonstrated benefit of improving bone-mineral density, protecting the eyes and skin from drying out, regulating the menstrual cycle, improving mental function, improving blood cholesterol and reducing hot flashes and night sweats associated with menopause", "There is no published evidence (derived from controlled research) supporting the claims of superior beneficial effects for bioidentical hormones as compared to conventional hormome therapy. Risk data have been published for conventional hormone therapy, and CHRT is not recommended to manage any chronic diseases, or for the prevention of cardiovascular disease"], ["[Estriol|Estriol]", "Estriol has been shown to cause breast cancer cell growth"], ["Pharmacists use their expertise regarding bioidentical hormones to meet the needs of their clients and improve health outcomes", "Compounding is a legitimate practice, but there is no evidence that clearly illustrates the benefits and risks of BHRT"]]}, "table-0403-805": {"title": ["Relative androgenic:anabolic activity in animals", "Relative androgenic:anabolic activity in animals"], "numCols": 2, "numericColumns": [], "pgTitle": "Anabolic steroid", "numDataRows": 6, "secondTitle": "Anabolic and androgenic effects", "numHeaderRows": 2, "caption": "Anabolic and androgenic effects", "data": [["[Testosterone|Testosterone]", "1:1"], ["[Methyltestosterone|Methyltestosterone]", "1:1"], ["[Fluoxymesterone|Fluoxymesterone]", "1:2"], ["[Oxymetholone|Oxymetholone]", "1:3"], ["[Oxandrolone|Oxandrolone]", "1:3\u20131:13"], ["[Nandrolone|Nandrolone]", "1:2.5\u20131:4"]]}, "table-0507-56": {"title": ["Test", "Patient type", "Lower limit", "Upper limit", "Unit"], "numCols": 5, "numericColumns": [2, 3], "pgTitle": "Reference ranges for blood tests", "numDataRows": 20, "secondTitle": "Thyroid hormones", "numHeaderRows": 1, "caption": "Thyroid hormones", "data": [["[Thyroid-stimulating_hormone|Thyroid stimulating hormone]", "[Reference_range|standard range]", "0.3, 0.4, 0.5, 0.6", "4.0, 4.5, 6.0", "mIU/L or \u03bcIU/mL"], ["[Thyroid-stimulating_hormone|Thyroid stimulating hormone]", "[Reference_range|optimal range]", "0.3, 0.5", "2.0, 3.0", "mIU/L or \u03bcIU/mL"], ["[Thyroid-stimulating_hormone|Thyroid stimulating hormone]", "[Infant|Infant]", "1.3", "19", "mIU/L or \u03bcIU/mL"], ["[Thyroid_hormone|thyroxine]", "Normal adult", "0.7, 0.8", "ng/dL", ""], ["[Thyroid_hormone|thyroxine]", "Normal adult", "9,", "18, 23", "pmol/L"], ["[Thyroid_hormone|thyroxine]", "Child/Adolescent 31 d - 18 y", "0.8", "2.0", "ng/dL"], ["[Thyroid_hormone|thyroxine]", "Child/Adolescent 31 d - 18 y", "10", "26", "pmol/L"], ["[Thyroid_hormone|thyroxine]", "Pregnant", "0.5", "1.0", "ng/dL"], ["[Thyroid_hormone|thyroxine]", "Pregnant", "6.5", "13", "pmol/L"], ["Total thyroxine", "", "4, 5.5", "11, 12.3", "\u03bcg/dL"], ["Total thyroxine", "", "60", "140, 160", "nmol/L"], ["[Triiodothyronine|triiodothyronine]", "Normal adult", "0.2", "0.5", "ng/dL"], ["[Triiodothyronine|triiodothyronine]", "Normal adult", "3.1", "7.7", "pmol/L"], ["[Triiodothyronine|triiodothyronine]", "Children 2-16 y", "0.1", "0.6", "ng/dL"], ["[Triiodothyronine|triiodothyronine]", "Children 2-16 y", "1.5", "9.2", "pmol/L"], ["[Triiodothyronine|triiodothyronine]", "", "60,", "175, 181", "ng/dL"], ["[Triiodothyronine|triiodothyronine]", "", "0.9, 1.1", "2.5, 2.7", "nmol/L"], ["[Thyroxine-binding_globulin|Thyroxine-binding globulin]", "", "12", "30", "mg/L"], ["[Thyroglobulin|Thyroglobulin]", "", "1.5", "30", "pmol/L"], ["[Thyroglobulin|Thyroglobulin]", "", "1", "20", "\u03bcg/L"]]}, "table-1379-82": {"title": ["System", "Condition", "System", "Condition"], "numCols": 4, "numericColumns": [], "pgTitle": "Childhood obesity", "numDataRows": 4, "secondTitle": "Effects on health", "numHeaderRows": 1, "caption": "Effects on health", "data": [["[Endocrine_system|Endocrine_system]", "[Diabetes_mellitus|Diabetes mellitus]", "[Circulatory_system|Circulatory_system]", "[Hypertension|Hypertension]"], ["[Human_gastrointestinal_tract|Gastroentestinal]", "[Non-alcoholic_fatty_liver_disease|Nonalcoholic fatty liver disease]", "[Respiratory_system|Respiratory]", "[Obstructive_sleep_apnea|Obstructive sleep apnea]"], ["[Human_musculoskeletal_system|Musculoskeletal]", "[Slipped_capital_femoral_epiphysis|Slipped capital femoral epiphysis]", "[Neurology|Neurology]", "[Idiopathic_intracranial_hypertension|Idiopathic intracranial hypertension]"], ["[Psychosocial|Psychosocial]", "[Anxiety|Anxiety]", "[Integument|Skin]", "[Boil|Boil]"]]}, "table-1650-920": {"title": ["Type of adenoma", "Secretion", "Staining", "Pathology", "Percentage of hormone production cases"], "numCols": 5, "numericColumns": [], "pgTitle": "Pituitary adenoma", "numDataRows": 6, "secondTitle": "Classification", "numHeaderRows": 1, "caption": "Classification", "data": [["[Prolactinoma|prolactinoma]", "[Prolactin|prolactin]", "[Acidophile_(histology)|acidophilic]", "[Galactorrhea|galactorrhea]", "30%"], ["[Somatotropic_cell|somatotrophic]", "[Growth_hormone|growth hormone]", "[Acidophile_(histology)|acidophilic]", "[Acromegaly|acromegaly]", "15%"], ["[Corticotropic_cell|corticotrophic]", "[Adrenocorticotropic_hormone|adenocorticotropic hormone]", "[Basophilic|basophilic]", "[Cushing's_disease|Cushing's disease]", ""], ["[Gonadotropic_cell|gonadotrophic]", "[Luteinizing_hormone|luteinizing hormone]", "[Basophil_cell|basophilic]", "usually doesn't cause symptoms", "10%"], ["[Thyrotropic_cell|thyrotrophic]", "[Thyroid-stimulating_hormone|thyroid-stimulating hormone]", "[Basophil_cell|basophilic to chromophobic]", "[Hyperthyroidism|hyperthyroidism]", "Less than 1%"], ["[Null_cell|null cell]", "do not secrete hormones", "[Synaptophysin|synaptophysin]", "", "25% of pituitary adenomas are nonsecretive"]]}, "table-1388-470": {"title": ["Location", "Name", "Description", "Secretion", "Staining"], "numCols": 5, "numericColumns": [], "pgTitle": "Fundic glands", "numDataRows": 4, "secondTitle": "Types of cells", "numHeaderRows": 1, "caption": "Types of cells", "data": [["Isthmus", "[Foveolar_cell|Mucous neck cells]", "[Gastric_pits|gastric pits]", "[Mucus|mucus]", "Clear"], ["Neck", "[Parietal_cell|parietal (oxyntic) cell]", "[Basement_membrane|basement membrane]", "[Gastric_acid|gastric acid]", "[Acidophile|Acidophile]"], ["Base", "[Gastric_chief_cell|chief (zymogenic) cell]", "[Epithelium|epithelium]", "[Pepsin|pepsinogen]", "[Basophilic|Basophilic]"], ["Base", "[Enteroendocrine_cell|enteroendocrine (APUD) cells]", "G cells are a type of enteroendocrine cell that secrete the hormone gastrin (gastrin promotes the secretion of pepsinogen (by chief cells) and HCl (by parietal cells) and promotes gastric contractions to mix contents).", "[Hormone|hormones]", "-"]]}, "table-1204-839": {"title": ["Time (h)", "Concentration of 4-methylaminorex in urine (\u00b5g/ml)"], "numCols": 2, "numericColumns": [1], "pgTitle": "4-Methylaminorex", "numDataRows": 4, "secondTitle": "Effects", "numHeaderRows": 1, "caption": "Effects", "data": [["0-6", "45"], ["6-24", "1.0"], ["24-36", "0.1"], ["36-48", "not detected"]]}, "table-1292-436": {"title": ["Layer of stomach", "Name", "Secretion", "Region of stomach", "Staining"], "numCols": 5, "numericColumns": [], "pgTitle": "Stomach", "numDataRows": 4, "secondTitle": "Glands", "numHeaderRows": 1, "caption": "Glands", "data": [["Isthmus of gland", "Mucous neck cells", "[Mucus|mucus]", "Fundic, cardiac, pyloric", "Clear"], ["Body of gland", "[Parietal_cell|parietal (oxyntic) cell]", "[Gastric_acid|gastric acid]", "Fundic only", "[Acidophile|Acidophile]"], ["Base of gland", "[Gastric_chief_cell|chief (zymogenic) cell]", "[Pepsin|pepsinogen]", "Fundic only", "[Basophilic|Basophilic]"], ["Base of gland", "[Enteroendocrine_cell|enteroendocrine (APUD) cells]", "[Hormone|hormones]", "Fundic, cardiac, pyloric", "\u2013"]]}, "table-1386-110": {"title": ["Maternal age at childbirth", "25", "30", "35", "40", "45"], "numCols": 6, "numericColumns": [1, 2, 3, 4, 5], "pgTitle": "Advanced maternal age", "numDataRows": 1, "secondTitle": "Other effects", "numHeaderRows": 1, "caption": "Other effects", "data": [["[Percentage|%]", "1.0", "1.6", "2.6", "3.8", "5.5"]]}, "table-1035-439": {"title": ["Mycotoxin", "Fungi", "Effect on animals"], "numCols": 3, "numericColumns": [], "pgTitle": "Mycotoxins in animal feed", "numDataRows": 6, "secondTitle": "Effects on animals", "numHeaderRows": 1, "caption": "Effects on animals", "data": [["[Aflatoxin|Aflatoxin]", "Aspergillus flavus, Aspergillus parasiticus", "[Carcinogen|carcinogenic]"], ["[Trichothecene|Trichothecene]", "Fusarium graminearum, Fusarium sporotrichioides", "[Edema|edema]"], ["[Zearalenone|Zearalenone]", "Fusarium graminearum", "[Estrogen|estrogenic]"], ["[Ochratoxin|Ochratoxin]", "Aspergillus ochraceus, Penicillium verrucosum", "nephrotoxicity, mild liver damage, immune suppression"], ["[Ergoline|Ergot alkaloid]", "Claviceps purpurea, Claviceps paspaspali", "nervous or gangrenous syndromes"], ["[Fumonisin|Fumonisin]", "Fusarium verticillioides, Fusarium proliferatum", "[Pulmonary_edema|pulmonary edema]"]]}, "table-0001-400": {"title": ["Dose (\u00b5g/kg/day)", "[Environmental_Working_Group|Environmental Working Group]", "Study Year"], "numCols": 3, "numericColumns": [0, 2], "pgTitle": "Bisphenol A", "numDataRows": 12, "secondTitle": "Low-dose exposure in animals", "numHeaderRows": 1, "caption": "Low-dose exposure in animals", "data": [["0.025", "\"Permanent changes to genital tract\"", "2005"], ["0.025", "\"Changes in breast tissue that predispose cells to hormones and carcinogens\"", "2005"], ["1", "long-term adverse reproductive and carcinogenic effects", "2009"], ["2", "\"increased prostate weight 30%\"", "1997"], ["2", "[Anogenital_distance|anogenital distance]", "[Digital_object_identifier|doi]"], ["2.4", "\"Decline in testicular testosterone\"", "2004"], ["2.5", "\"Breast cells predisposed to cancer\"", "2007"], ["10", "\"Prostate cells more sensitive to hormones and cancer\"", "2006"], ["10", "\"Decreased maternal behaviors\"", "2002"], ["30", "\"Reversed the normal sex differences in brain structure and behavior\"", "2003"], ["50", "[Primate|non-human primates]", "2008"], ["50", "Disrupts ovarian development", "2009"]]}, "table-1640-953": {"title": ["Strain", "Brandname", "Producer", "Proven effect in humans"], "numCols": 4, "numericColumns": [], "pgTitle": "Lactobacillus acidophilus", "numDataRows": 3, "secondTitle": "Strains with described health effects", "numHeaderRows": 1, "caption": "Strains with described health effects", "data": [["Lactobacillus acidophilus DDS-1", "", "Nebraska Cultures", ""], ["Lactobacillus acidophilus LA-5", "", "[Chr._Hansen|Chr. Hansen]", ""], ["Lactobacillus acidophilus NCFM", "", "[Danisco|Danisco]", ""]]}, "table-0985-943": {"title": ["Foods", "Reducing acid present"], "numCols": 2, "numericColumns": [], "pgTitle": "Antioxidant", "numDataRows": 3, "secondTitle": "Adverse effects", "numHeaderRows": 1, "caption": "Adverse effects", "data": [["[Cocoa_bean|Cocoa bean]", "[Oxalic_acid|Oxalic acid]"], ["[Whole_grain|Whole grain]", "[Phytic_acid|Phytic acid]"], ["[Bean|bean]", "[Tannin|Tannin]"]]}, "table-1205-318": {"title": ["Method", "Function", "Significance"], "numCols": 3, "numericColumns": [], "pgTitle": "Biological basis of personality", "numDataRows": 5, "secondTitle": "Experimental Techniques", "numHeaderRows": 1, "caption": "Experimental Techniques", "data": [["[Electroencephalography|Electroencephalography]", "[Temporal_resolution|temporal resolution]", "Before the advent of brain imaging technology, the only method to measure brain activity was electroencephalography (EEG)."], ["Brain Imaging", "[Positron_emission_tomography|Positron Emission Tomography]", "The development of brain imaging technology has not only allowed for, but has served as a catalyst to the investigation of how the brain contributes to personality."], ["[Molecular_genetics|Molecular Genetics]", "This method is used to analyze a gene-trait link, by measuring the structure and function of genes in the brain.", "The use of molecular genetics in biology-based personality research is expected to grow."], ["[Assay|Assay]", "This method is used to analyze the amount of psychoactive substances, such as hormones and neurotransmitters.", "[Personality_disorder|personality disorder]"], ["Pharmacological Manipulation", "This method is used to alter the levels of biochemicals, and observe the effects on behavior.", "[Personality_disorder|personality disorder]"]]}, "table-1363-588": {"title": ["Dosage", "Duration"], "numCols": 2, "numericColumns": [], "pgTitle": "2C-E", "numDataRows": 4, "secondTitle": "Adverse effects", "numHeaderRows": 1, "caption": "Adverse effects", "data": [["10mg", "6-8 Hours"], ["20mg", "8-10 Hours"], ["30mg", "15-20 Hours"], ["40mg", "24+ hours"]]}, "table-1017-458": {"title": ["Generic name", "Brand names", "Common uses", "Possible adverse effects", "Mechanism of action"], "numCols": 5, "numericColumns": [], "pgTitle": "List of antipsychotics", "numDataRows": 39, "secondTitle": "", "numHeaderRows": 2, "caption": "Antipsychotics by class", "data": [["[Chlorpromazine|Chlorpromazine]", "Largactil, Thorazine", "application", "adverse effects", "action."], ["[Thioridazine|Thioridazine]", "Mellaril, Melleril, Novoridazine, Thioril", "application", "adverse effects", "action."], ["[Mesoridazine|Mesoridazine]", "Serentil", "application", "adverse effects", "action."], ["[Levomepromazine|Levomepromazine]", "Nosinan, Nozinan, Levoprome", "application", "adverse effects", "action."], ["[Loxapine|Loxapine]", "Loxapac, Loxitane", "application", "adverse effects", "action."], ["[Molindone|Molindone]", "Moban", "application", "adverse effects", "action."], ["[Perphenazine|Perphenazine]", "Trilafon", "application", "adverse effects", "action."], ["[Thiothixene|Thiothixene]", "Navane", "application", "adverse effects", "action."], ["[Trifluoperazine|Trifluoperazine]", "Stelazine", "application", "adverse effects", "action."], ["[Haloperidol|Haloperidol]", "Haldol", "application", "adverse effects", "action."], ["[Fluphenazine|Fluphenazine]", "Prolixin", "application", "adverse effects", "action."], ["[Droperidol|Droperidol]", "[Fentanyl|Fentanyl]", "application", "adverse effects", "action."], ["[Zuclopenthixol|Zuclopenthixol]", "Clopixol", "application", "adverse effects", "action."], ["[Prochlorperazine|Prochlorperazine]", "Compazine, Stemzine, Buccastem, Stemetil, Phenotil", "application", "adverse effects", "action."], ["[Atypical_antipsychotic|atypical antipsychotic]", "[Atypical_antipsychotic|atypical antipsychotic]", "[Atypical_antipsychotic|atypical antipsychotic]", "[Atypical_antipsychotic|atypical antipsychotic]", "[Atypical_antipsychotic|atypical antipsychotic]"], ["[Amisulpride|Amisulpride ]", "Solian", "application", "adverse effects", "action."], ["[Aripiprazole|Aripiprazole]", "Abilify", "application", "adverse effects", "action."], ["[Asenapine|Asenapine]", "Saphris", "application", "adverse effects", "action."], ["[Blonanserin|Blonanserin]", "Lonasen", "application", "adverse effects", "action."], ["[Clotiapine|Clotiapine]", "Entumine", "application", "adverse effects", "action."], ["[Clozapine|Clozapine]", "Clozaril", "application", "adverse effects", "action."], ["[Iloperidone|Iloperidone]", "Fanapt", "application", "adverse effects", "action."], ["[Lurasidone|Lurasidone]", "Latuda", "application", "adverse effects", "action."], ["[Mosapramine|Mosapramine]", "Cremin", "application", "adverse effects", "action."], ["[Olanzapine|Olanzapine]", "Zyprexa, Ozace", "application", "adverse effects", "action."], ["[Paliperidone|Paliperidone]", "Invega", "application", "adverse effects", "action."], ["[Perospirone|Perospirone]", "Lullan", "application", "adverse effects", "action."], ["[Quetiapine|Quetiapine]", "Seroquel", "application", "adverse effects", "action."], ["[Remoxipride|Remoxipride]", "Roxiam", "application", "adverse effects", "action."], ["[Risperidone|Risperidone]", "Risperdal, Zepidone", "application", "adverse effects", "action."], ["[Sertindole|Sertindole]", "Serdolect", "application", "adverse effects", "action."], ["[Sulpiride|Sulpiride]", "Sulpirid, Eglonyl", "application", "adverse effects", "action."], ["[Ziprasidone|Ziprasidone]", "Geodon, Zeldox", "application", "adverse effects", "action."], ["[Zotepine|Zotepine]", "Nipolept", "application", "adverse effects", "action."], ["under development", "under development", "under development", "under development", "under development"], ["[Bifeprunox|Bifeprunox]", "DU-127,090", "", "", ""], ["[Pimavanserin|Pimavanserin]", "ACP-103", "", "", ""], ["[Vabicaserin|Vabicaserin]", "SCA-136", "", "", ""], ["Generic Name", "Brand Names", "Common Uses", "Possible adverse effects", "Mechanism of action"]]}, "table-0571-533": {"title": ["[Acetylcholinesterase_inhibitor|acetylcholinesterase inhibitors]", "[Acetylcholinesterase_inhibitor|acetylcholinesterase inhibitors]", "[Acetylcholinesterase_inhibitor|acetylcholinesterase inhibitors]"], "numCols": 3, "numericColumns": [], "pgTitle": "Acetylcholinesterase inhibitor", "numDataRows": 1, "secondTitle": "Effects", "numHeaderRows": 2, "caption": "Effects", "data": [["[Diarrhea|Diarrhea]", "[Abdominal_pain|Abdominal pain]", ""]]}}